Which Antidepressants Should be Tapered When Stopping +++ (Medscape AI)

Medscape AI • Which Antidepressants Should be Tapered When Stopping? A gradual dose reduction is generally advised for all antidepressants that carry a risk of discontinuation symptoms, but special caution is warranted with agents that have short half-lives or potent serotonergic activity. https://www.medscape.com/ai-search?query=Which%20Antidepressants%20Should%20be%20Tapered%20When%20Stopping&&ecd=mkm_ret_260108_mscpmrk-OUS_BO_etid8010195&uac=148436CN&impID=8010195 • What's The Newest Evidence in Treating Lupus Nephritis? Recent phase III trials have led to three novel agents receiving FDA approval for active lupus nephritis when added to standard immunosuppression. https://www.medscape.com/ai-search?query=Whats%20The%20Newest%20Evidence%20in%20Treating%20Lupus%20Nephritis&&ecd=mkm_ret_260108_mscpmrk-OUS_BO_etid8010195&uac=148436CN&impID=8010195 • How do GLP1s and Metformin Impact Dementia Risk? GLP-1 receptor agonists and metformin have both been investigated for potential neuroprotective effects in patients with type 2 diabetes, with emerging data suggesting differential impacts on dementia risk. https://www.medscape.com/ai-search?query=How%20Do%20GLP1s%20and%20Metformin%20Impact%20Dementia%20Risk&&ecd=mkm_ret_260108_mscpmrk-OUS_BO_etid8010195&uac=148436CN&impID=8010195